Antimicrobial peptides
Antimicrobial Peptides :
1. Introduction to AMPs :
★AMPs are small, naturally occurring proteins (typically 10–100 amino acids) that play a crucial role in innate immunity.
★They exhibit broad-spectrum activity against bacteria, fungi, viruses, and even cancer cells.
★Common examples: Defensins, Cathelicidins, Magainins, LL-37.
2. Sources of AMPs :
Natural Sources:
Animals: Skin, epithelial cells, neutrophils (e.g., defensins from humans).
Plants: Thionins, defensins.
Microorganisms: Bacteriocins from bacteria.
Marine organisms: Tunicates, sponges, and mollusks.
Synthetic Sources:
Designed based on known AMP structures or generated through bioinformatics tools.
3. Methods of Production
A. Chemical Synthesis
★Solid Phase Peptide Synthesis (SPPS):
★Uses stepwise addition of amino acids on a resin.
★Suitable for peptides <50 amino acids.
★High purity but expensive and less efficient for long peptides.
Advantages:
>High purity.
>Incorporation of modified amino acids.
Disadvantages:
>High cost.
>Not ideal for large-scale production.
B. Recombinant Expression Systems
Used to produce larger quantities at lower cost.
1. Bacterial Systems (e.g., E. coli)
>Most common system.
>AMPs often toxic to host, so fusion proteins are used.
>Requires cleavage and purification.
2. Yeast Systems (e.g., Pichia pastoris)
>Secretion of peptides into medium.
>Better folding and post-translational modifications.
3. Insect Cells (Baculovirus System)
>High expression levels.
>Suitable for peptides needing complex modifications.
4. Mammalian Cells
>Expensive, used when correct folding and PTMs are essential.
5. Plant-based Systems
>Cost-effective and safe.
>Transgenic plants can produce AMPs in seeds or leaves.
4. Fusion Tags for AMP Production
>Fusion tags improve expression, solubility, and protect the host from AMP toxicity.
>Common tags: GST, MBP, His-tag, SUMO.
>Cleaved post-expression using proteases (e.g., thrombin, TEV).
5. Purification of AMPs
>Affinity Chromatography: Using tags like His-tag (Ni-NTA column).
>Ion Exchange Chromatography: Based on charge differences.
>Reverse-Phase HPLC: For final purification and analysis.
>Size-Exclusion Chromatography: For size-based separation.
6. Characterization of AMPs
>Mass Spectrometry (MS) – Molecular weight.
>Circular Dichroism (CD) Spectroscopy – Secondary structure.
>NMR / X-ray Crystallography – 3D structure.
>Antimicrobial Assays – MIC determination against microbes.
7. Challenges in AMP Production
>Cytotoxicity to host cells.
>Proteolytic degradation.
>Low expression yields.
>High cost of synthesis/purification.
8. Future Prospects and Trends
>In silico design of synthetic AMPs with enhanced stability and activity.
>Peptidomimetics: Synthetic analogs with improved properties.
>Encapsulation and delivery strategies to improve AMP stability in vivo.